Physician profile
Alex Johnson
NPI 1417081399
$3,281.03
in general payments reported to CMS, 2019-2025
13 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $106 · 2021: $27.90 · 2022: $331 · 2023: $2,049 · 2024: $250 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Travel and Lodging: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.21 |
| Travel and Lodging | $1,011.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,220.21 | 2019-2024 | Optis, Cardiomems |
| Abiomed | $371.38 | 2022-2024 | Impella |
| Boston Scientific Corporation | $159.00 | 2023-2025 | Avvigo Guidance System |
| Novartis Pharmaceuticals Corporation | $137.62 | 2021-2025 | |
| Teleflex LLC | $117.39 | 2019-2025 | Turnpike |
| Atricure, INC. | $98.38 | 2019 | |
| Pfizer INC. | $46.23 | 2021-2024 | |
| Medtronic, INC. | $31.51 | 2022-2024 | Aurora Ev-Icd Mri Surescan |
| Siemens Medical Solutions USA, INC. | $25.53 | 2023 | Biograph Mct X-4r |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.73 | 2025 | Lifevest |
| Livanova USA, INC. | $23.10 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.75 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.